These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 22905031)
1. Resistance of Francisella novicida to fosmidomycin associated with mutations in the glycerol-3-phosphate transporter. Mackie RS; McKenney ES; van Hoek ML Front Microbiol; 2012; 3():226. PubMed ID: 22905031 [TBL] [Abstract][Full Text] [Related]
2. Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr). Armstrong CM; Meyers DJ; Imlay LS; Freel Meyers C; Odom AR Antimicrob Agents Chemother; 2015 Sep; 59(9):5511-9. PubMed ID: 26124156 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of DXR in the MEP pathway with lipophilic Bague D; Wang R; Hodge D; Mikati MO; Roma JS; Boshoff HI; Dailey AL; Girma M; Couch RD; Odom John AR; Dowd CS RSC Med Chem; 2024 Jul; 15(7):2422-2439. PubMed ID: 39026652 [TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Bioactivity Evaluation of Heterocycle-Containing Mono- and Bisphosphonic Acid Compounds. Wu X; Yang Z; Bu M; Duan J; Zhang A Molecules; 2023 Nov; 28(22):. PubMed ID: 38005231 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of the Fosmidomycin analogue FR 900098 with substituted 2-oxazolines against Stephens MD; Yodsanit N; Melander C Medchemcomm; 2016; 7(10):1952-1956. PubMed ID: 28154750 [TBL] [Abstract][Full Text] [Related]
10. Identification of an N-terminal tag (580N) that improves the biosynthesis of fluorescent proteins in Francisella tularensis and other Gram-negative bacteria. Haggerty K; Cantlay S; Young E; Cashbaugh MK; Delatore Iii EF; Schreiber R; Hess H; Komlosi DR; Butler S; Bolon D; Evangelista T; Hager T; Kelly C; Phillips K; Voellinger J; Shanks RMQ; Horzempa J Mol Cell Probes; 2024 Apr; 74():101956. PubMed ID: 38492609 [TBL] [Abstract][Full Text] [Related]
11. Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities. Knak T; Abdullaziz MA; Höfmann S; Alves Avelar LA; Klein S; Martin M; Fischer M; Tanaka N; Kurz T Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559004 [TBL] [Abstract][Full Text] [Related]
12. GAPDH mediates drug resistance and metabolism in Plasmodium falciparum malaria parasites. Jezewski AJ; Guggisberg AM; Hodge DM; Ghebremichael N; John GN; McLellan LK; Odom John AR PLoS Pathog; 2022 Sep; 18(9):e1010803. PubMed ID: 36103572 [TBL] [Abstract][Full Text] [Related]
13. Structure-guided microbial targeting of antistaphylococcal prodrugs. Miller JJ; Shah IT; Hatten J; Barekatain Y; Mueller EA; Moustafa AM; Edwards RL; Dowd CS; Hoops GC; Johnson RJ; Planet PJ; Muller FL; Jez JM; Odom John AR Elife; 2021 Jul; 10():. PubMed ID: 34279224 [TBL] [Abstract][Full Text] [Related]
14. Genetic Determinants of Antibiotic Resistance in Kassinger SJ; van Hoek ML Front Microbiol; 2021; 12():644855. PubMed ID: 34054749 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloB. Mikati MO; Miller JJ; Osbourn DM; Barekatain Y; Ghebremichael N; Shah IT; Burnham CD; Heidel KM; Yan VC; Muller FL; Dowd CS; Edwards RL; Odom John AR ACS Infect Dis; 2020 Nov; 6(11):3064-3075. PubMed ID: 33118347 [TBL] [Abstract][Full Text] [Related]
16. Potent, specific MEPicides for treatment of zoonotic staphylococci. Edwards RL; Heueck I; Lee SG; Shah IT; Miller JJ; Jezewski AJ; Mikati MO; Wang X; Brothers RC; Heidel KM; Osbourn DM; Burnham CD; Alvarez S; Fritz SA; Dowd CS; Jez JM; Odom John AR PLoS Pathog; 2020 Jun; 16(6):e1007806. PubMed ID: 32497104 [TBL] [Abstract][Full Text] [Related]